Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Individual Reminiscence Therapy in the Elderly People With Neurocognitive Disorders: A Multicentre Randomised Controlled Trial in Azores Archipelago

NCT04658394 is registered in ClinicalTrials.gov with Rsocialform - Geriatria, Lda as lead sponsor.

NCT NCT04658394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04658394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Individual Reminiscence Therapy in the Elderly People With Neurocognitive Disorders: A Multicentre Randomised Controlled Trial in Azores Archipelago
Lead sponsor
Rsocialform - Geriatria, Lda
Phase
Not applicable
Overall status
Completed
Start date
February 11, 2021
Completion date
August 31, 2021
Enrollment
122 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive decline, cognitive dysfunction, cognitive impairment, dementia, neurocognitive disorders